report street estim revenu
line pre-announce street previous ep
penni better consensu compani rais guidanc although guid
lower consensu continu believ core move right direct
remain ow share rais price target reflect
ep previous
result report cc organ revenu growth
consensu previou breast health diagnost drove
beat breast health grow cc street
diagnost grow cc street gyn surgic grew
cc street skelet health grew line
consensu medic aesthet cynosur recoveri remain neutral gear follow
fda warn declin cc street adj gross margin
declin due geographi product mix oper expens
increas exclud two acquisit actual improv fx trim
partial off-set share count yield ep street
guidanc rais guidanc guid lower street
revenu cc growth
street non-gaap ep
street acknowledg fx headwind view guidanc
busi updat manag remain bullish extend cycl breast health
note pick growth exist custom upgrad
new product intervent busi flat adjust acquisit
manag believ return organ growth increas relat
consum product extend refer lab deal labcorp
quest word ad viral contract lastli manag remain
bullish cynosur long-term potenti acknowledg take
renew sale effort includ addit market new product start
meaning contribut result
price close januari
ep
debt total capit
reiter overweight view quarter posit believ
guidanc reason accordingli increas price target
reflect ep estim
new product adopt fda regul competit acquisit integr
inc focus provid health care product women
ep exclud one-tim item includ sbc
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
thousand
provis incom tax
product sale
good sold product sale
compani report piper jaffray co current disclosur inform compani locat
page
